Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037580 | SCV000061238 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | Arg9Arg in exon 2 of PLN: This variant is not expected to have clinical signific ance because it does not alter an amino acid residue and is not located within t he splice consensus sequence. It has been identified in 0.1% (6/7020) of Europea n American chromosomes from a broad population by the NHLBI Exome Sequencing Pro ject (http://evs.gs.washington.edu/EVS; dbSNP rs145623013). Arg9Arg in exon 2 o f PLN (rs145623013; 0.1%, 6/7020) ** |
Gene |
RCV000037580 | SCV000514182 | benign | not specified | 2015-04-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000465487 | SCV000561621 | likely benign | Dilated cardiomyopathy 1P | 2025-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621419 | SCV000740057 | likely benign | Cardiovascular phenotype | 2016-10-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769214 | SCV000900590 | likely benign | Cardiomyopathy | 2017-10-06 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000465487 | SCV001316972 | uncertain significance | Dilated cardiomyopathy 1P | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000037580 | SCV001361671 | benign | not specified | 2019-11-16 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001529611 | SCV002047764 | likely benign | not provided | 2024-05-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001529611 | SCV003917092 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | PLN: BP4, BP7 |
Diagnostic Laboratory, |
RCV001529611 | SCV001743348 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529611 | SCV001928301 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529611 | SCV001952296 | likely benign | not provided | no assertion criteria provided | clinical testing |